The skeleton in the closet

Gene

Volumn 528, Issue 1, 2013, Pages 7-11

  Kaplan, Frederick S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Fibrodysplasia ossificans progressiva

Indexed keywords

ARTICLE; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; HUMAN; PHYSICIAN; PRIORITY JOURNAL; SCIENTIST; SKELETON; SKELETON MALFORMATION;

ACTIVIN A RECEPTOR, TYPE I/ACTIVIN RECEPTOR-LIKE KINASE 2; ACVR1/ALK2; BMP; BONE MORPHOGENETIC PROTEIN; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP;

BONE AND BONES; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MUSEUMS; MUTATION, MISSENSE; MYOSITIS OSSIFICANS; PHILADELPHIA; SKELETON;

EID: 84882579079     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.06.022     Document Type: Article

References (26)

1. Berglas N. Fibrodysplasia ossificans progressiva (FOP) and the myth of Lot's wife. J. Ortho. U. Penn. 1993, 9:52-53.
2. Chakkalakal S.A., et al. An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. J. Bone Miner. Res. 2012, 27:1746-1756.
3. Faulkner W. Speech at the Nobel Banquet at the City Hall in Stockholm on December 10, 1950 1950, (Nobelprize.org).
4. Hong C.C., Yu P.B. Applications of small molecule BMP inhibitors in physiology and disease. Cytokine Growth Factor Rev. 2009, 20:409-418.
5. Kantanie S. To Harry, with gratitude. FOP Connect. 2000, 13(4):1-3.
6. Kaplan F.S. Fibrodysplasia ossificans progressiva (FOP) (1692-1992): the three-hundredth anniversary of ignorance. J. Ortho. U. Penn. 1993, 9:81-83.
7. Kaplan F.S. The metamorphosis. Clin. Orthop. 1998, 346:2-3.
8. Kaplan F.S. The key to the closet is the key to the kingdom: a common lesson of rare diseases. Orphanet Dis. Update 2006, 24(3):1-9.
9. Kaplan F.S., Shore E.M. Derailing heterotopic ossification and RARing to go. Nat. Med. 2011, 17:420-421.
10. Kaplan F.S., et al. Fibrodysplasia ossificans progressiva. Best Pract. Res. Clin. Rheumatol. 2008, 22:191-205.
11. Kaplan F.S., Groppe J., Shore E.M. When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP). Drug Discov. Today Ther. Strateg. 2009, 5:255-262.
12. Kaplan F.S., Zasloff M.A., Kitterman J.A., Shore E.M., Hong C.C., Rocke D.M. Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J. Bone Joint Surg. Am. 2010, 92:686-691.
13. Kaplan F.S., Lounev V.Y., Wang H., Pignolo R.J., Shore E.M. Fibrodysplasia ossificans progressiva: a blueprint for the metamorphosis. Ann. N. Y. Acad. Sci. 2011, 1237:5-10.
14. Kaplan F.S., Chakkalakal S.A., Shore E.M. Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis. Dis. Model. Mech. 2012, 5:756-762.
15. Kaplan J., Kaplan F.S., Shore E.M. Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting. Gene Ther. 2012, 19:786-790.
16. Kitterman J.A., Kantanie S., Rocke D.M., Kaplan F.S. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics 2005, 116:654-661.
17. Lounev V., et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J. Bone Joint Surg. Am. 2009, 91:652-663.
18. Maeder T. A few hundred people turned to bone. Atlantic Mon. 1998, 281(2):81-89.
19. McKusick V.A. Heritable Disorders of Connective Tissue 1972, C.V. Mosby Company, Saint Louis. 4th ed.
20. Medici D., Shore E.M., Lounev V.Y., Kaplan F.S., Kalluri R., Olsen B.J. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat. Med. 2010, 16:1400-1406.
21. Peltier L.F. A case of extraordinary exostoses on the back of a boy. Clin. Orthop. 1998, 346:5-6.
22. Rosenstirn J.A. A contribution to the study of myositis ossificans progressiva. Ann. Surg. 1918, 68:485-520. (591-637).
23. Shafritz A.B., et al. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva (FOP). N. Engl. J. Med. 1996, 335:555-561.
24. Shimono K., et al. Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists. Nat. Med. 2011, 17:454-460.
25. Shore E.M., Kaplan F.S. Inherited human diseases of heterotopic bone formation. Nat. Rev. Rheumatol. 2010, 6:518-527.
26. Shore E.M., et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet. 2006, 38:525-527.